Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept vs Hydroxychloroquine in Palindromic Rheumatism
NCT03669367Phase 4Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Jun 2019
- Primary completion
- Jun 2022
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of abatacept in palindromic rheumatism (PR), sponsored by Fundació Clínic per a la Recerca Biomèdica. Started Jun 2019; status: completed.
02
Drugs
abatacept
03
Conditions
palindromic rheumatism (PR)
Beyond the preview
Go deeper on NCT03669367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03669367.